Dry Age Related Macular Degeneration (AMD) Market Overview 2025: Competitive Shifts, Forecast Models, and Emerging Opportunities
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Are the Projected Market Size and Growth Rates for the Dry Age Related Macular Degeneration (AMD) Market From 2025 To 2029?
The market size of dry age related macular degeneration (AMD) has recently seen robust growth. An increase from $4.49 billion in 2024 to $4.90 billion in 2025, showing a compound annual growth rate (CAGR) of 9.1%, is projected. The growth observed in the historic period is thanks to factors such as a growing elderly population, a higher incidence of chronic diseases, heightened awareness of eye health, an increase in clinical trials targeted towards dry AMD, and a rising demand for treatments that are minimally invasive.
The market for dry age related macular degeneration (AMD) is projected to witness robust expansion in the upcoming years, escalating to $6.86 billion in 2029 with a compound annual growth rate (CAGR) of 8.8%. The potential growth during the forecasted timeline can be ascribed to the advent of innovative therapies, ascend in health care expenditures, increased adoption of laser photocoagulation therapy, enhancements in genetic studies, and an intensified emphasis on personalized medication. Key trends anticipated during the forecast period comprise of progression in diagnostic technologies, increased acceptance of teleophthalmology, technologically evolved treatment methods, product certifications, and introduction of new products.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21176&type=smp
What Are the Core Growth Drivers Propelling the Dry Age Related Macular Degeneration (AMD) Market Forward?
The anticipated expansion of the dry age related macular degeneration (AMD) market is attributed to the escalating elderly population. The term ‘elderly population’ typically denotes individuals who are 65 years or more. A variety of factors, including advances in medical technology, successful management of chronic conditions, longer lifespan, and improved care for the elderly, contribute to the progressive increase in this demographic group. Dry age-related macular degeneration (AMD) benefits the elderly by offering specific treatments and management tactics aimed at slowing disease advancement, conserving vision, and improving quality of life for those impacted by this ailment. For example, reports released by the National Council on Aging, a US-based entity, stated in June 2024, that there were about 57.8 million seniors, making up 17.3% of the total U.S. population in 2022. This was a surge from 16.9% in 2021. Hence, the swelling elderly populous will steer the growth of the dry age-related macular degeneration (AMD) market.
What Segment Types Define the Dry Age Related Macular Degeneration (AMD) Market Structure?
The dry age related macular degeneration (AMD) market covered in this report is segmented –
1) By Stages: Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration
2) By Age Group: Above 75 Years, Above 60 Years, Above 40 Years
3) By Route Of Administration: Oral, Injectables
4) By End Users: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes
Subsegments:
1) By Early Age-Related Macular Degeneration: Drusen Accumulation, Retinal Pigment Epithelium Changes
2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits, Increased Pigmentary Abnormalities
3) By Late Age-Related Macular Degeneration: Geographic Atrophy, Central Vision Loss
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21176&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Dry Age Related Macular Degeneration (AMD) Market?
North America was the largest region in the dry age-related macular degeneration (AMD) market in 2024. The regions covered in the dry age related macular degeneration (AMD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Emerging Trends that Are Influencing theDry Age Related Macular Degeneration (AMD) Industry Evolution?
Leading firms in the dry age-related macular degeneration (AMD) market are scrutinizing new innovative technologies and therapies, like light delivery systems, to stimulate and interact with retinal cells, which could potentially decelerate the progression of the disease. These light delivery systems are technologies specifically tailored to convey light for healing purposes, especially in medical treatments. For example, in January 2024, LumiThera Inc., a company that creates medical devices and is based in the US, introduced a photobiomodulation (PBM) for dry AMD utilizing the Valeda Light Delivery System. This is the inaugural therapy approved by the FDA that is engineered to tackle vision loss in patients with dry AMD, a condition with very few treatment options. To collect extensive data on patient outcomes who have been treated with the Valeda system, LumiThera kickstarted the EUROLIGHT registry study. The Valeda system applies a diverse wavelength light delivery technique that operates with three specific wavelengths (590 nm, 660 nm, and 850 nm). This non-invasive treatment can be delivered via an open or closed eyelid and is usually conducted over three to four weeks in roughly nine sessions.
View the full report here:
What Is the Definition of the Dry Age Related Macular Degeneration (AMD) Market?
Dry age related macular degeneration (AMD) refers to a progressive eye condition characterized by the gradual deterioration of the macula, the central part of the retina, leading to blurred central vision. They are used for managing and slowing the progression of the disease through treatments like vitamins, nutritional supplements, and emerging pharmaceutical therapies.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21176
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
